Skip to main content
Journal cover image

Benefits of prophylactic short-course immunomodulation in patients with infantile Pompe disease: Demonstration of long-term safety and efficacy in a large cohort

Publication ,  Conference
Desai, AK; Li, C; Rosenberg, AS; Kishnani, PS
Published in: Molecular Genetics and Metabolism
February 2020

Duke Scholars

Published In

Molecular Genetics and Metabolism

DOI

ISSN

1096-7192

Publication Date

February 2020

Volume

129

Issue

2

Start / End Page

S48 / S48

Publisher

Elsevier BV

Related Subject Headings

  • Genetics & Heredity
  • 3202 Clinical sciences
  • 3105 Genetics
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Desai, A. K., Li, C., Rosenberg, A. S., & Kishnani, P. S. (2020). Benefits of prophylactic short-course immunomodulation in patients with infantile Pompe disease: Demonstration of long-term safety and efficacy in a large cohort. In Molecular Genetics and Metabolism (Vol. 129, pp. S48–S48). Elsevier BV. https://doi.org/10.1016/j.ymgme.2019.11.104
Desai, Ankit K., Cindy Li, Amy S. Rosenberg, and Priya S. Kishnani. “Benefits of prophylactic short-course immunomodulation in patients with infantile Pompe disease: Demonstration of long-term safety and efficacy in a large cohort.” In Molecular Genetics and Metabolism, 129:S48–S48. Elsevier BV, 2020. https://doi.org/10.1016/j.ymgme.2019.11.104.
Desai AK, Li C, Rosenberg AS, Kishnani PS. Benefits of prophylactic short-course immunomodulation in patients with infantile Pompe disease: Demonstration of long-term safety and efficacy in a large cohort. In: Molecular Genetics and Metabolism. Elsevier BV; 2020. p. S48–S48.
Desai, Ankit K., et al. “Benefits of prophylactic short-course immunomodulation in patients with infantile Pompe disease: Demonstration of long-term safety and efficacy in a large cohort.” Molecular Genetics and Metabolism, vol. 129, no. 2, Elsevier BV, 2020, pp. S48–S48. Crossref, doi:10.1016/j.ymgme.2019.11.104.
Desai AK, Li C, Rosenberg AS, Kishnani PS. Benefits of prophylactic short-course immunomodulation in patients with infantile Pompe disease: Demonstration of long-term safety and efficacy in a large cohort. Molecular Genetics and Metabolism. Elsevier BV; 2020. p. S48–S48.
Journal cover image

Published In

Molecular Genetics and Metabolism

DOI

ISSN

1096-7192

Publication Date

February 2020

Volume

129

Issue

2

Start / End Page

S48 / S48

Publisher

Elsevier BV

Related Subject Headings

  • Genetics & Heredity
  • 3202 Clinical sciences
  • 3105 Genetics
  • 1103 Clinical Sciences